Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization

Hepato-Gastroenterology

Volumn 43, Issue 9, 1996, Pages 644-650

  Ishii, Hiroshi ^a   Okada, Shuichi ^a   Sato, Tosiya ^b   Nose, Haruhiko ^a   Okusaka, Takuji ^a   Yoshimori, Masayoshi ^a   Takayasu, Kenichi ^a   Takayama, Tadatoshi ^a   Kosuge, Tomoo ^a   Yamasaki, Susumu ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b INSTITUTE OF STATISTICAL MATHEMATICS   (Japan)

Author keywords

Hepatocellular carcinoma; Percutaneous ethanol injection; Recurrence; Transcatheter arterial embolization

Indexed keywords

ALCOHOL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECURRENT CANCER; REGRESSION ANALYSIS; SURVIVAL TIME;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; EMBOLIZATION, THERAPEUTIC; ETHANOL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TIME FACTORS;

EID: 8944229197     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kosuge T, Makuuchi M, Takayama, et al. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepato-Gastroenterol 1993; 40: 328-32.
2. Kanematsu T, Matsunuma T, Takenaka K, et al. Clinical management of recurrent hepatocellular carcinoma alter primary resection. Br J Surg 1988; 75: 203-6.
3. Belghili J, Panis Y, Farges O, et al. Intrahepatic recurrence alter resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214: 114-7.
4. Takayasu K, Wakao F, Moriyama N, et al. Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors. Hepatology 1992; 16: 906-11.
5. Okazaki M, Yamasaki S, Ono H, et al. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver alter hepatectomy. Hepato-gastroenterol 1993; 40: 320-3.
6. Sugiura N, Takara K, Ohto M, et al. Treatment of small hepatocellular carcinoma by percutaneous injection of ethanol into tumor with real-time ultrasound monitering. Acta Hepatol Jpn. 1983; 24: 920.
7. Ebara M, Kita K, Yoshikawa M, et al. Percutaneous ethanol injection for patients with small hepatocellular carcinoma. In: Tobe T, et al. eds. Primary liver cancer in Japan. Springer-Verlag Tokyo 1992; 291-300.
8. Tanikawa K, Majima Y. Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma. Hepato-gastroenterol 1993; 40: 324-7.
9. Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR 1993; 160: 1023-8.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 63: 457-481.
11. Cox DR. Regression models and life-tables [with discussion]. J R Stat Soc 1972; 34 [Series B]: 187-220.
12. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. American Journal of Epidemiology 1989; 129: 125-37.
13. Okada S, Okazaki N, Nose H, et al. Prognostic factors with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 1992; 16: 112-7.
14. Nakamura H, Liu T, Hori S, et al. Response to transcatheter oily chemoembolization in hepatocellular carcinoma 3 cm or less: a study in 50 patients who underwent surgery. Hepato-gastroenterol 1993; 40: 6-9.
15. Sheu JC, Sung JL, Huang GT, et al. Intratumor injection of absolute ethanol under ultrasound guidance for the treatment of small hepatocellular carcinoma. Mepato-gastroenterol 1987; 34: 255-61.
16. Seki T, Nonaka T, Kubota Y, et al. Ultrasonically guided percutaneous ethanol injection therapy for hepatocellular carcinoma. Am J Gastroenterol 1989; 84: 1400-7.
17. Shiina S, Tagawa K, Unuma T, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study. Cancer 1991; 68: 1524-30.